Guardian Pharmacy Services completes $181 million follow-on public offering, including “synthetic secondary” transaction

Client(s) Guardian Pharmacy Services, Inc.

Jones Day represented Guardian Pharmacy Services, Inc. (NYSE: GRDN), a leading long-term care pharmacy services company, in connection with its $181 million underwritten follow-on public offering. The offering consisted of a secondary offering of 7,184,553 shares of Class A Common Stock by selling stockholders and a primary offering of 1,440,447 shares of Class A Common Stock, at a public offering price of $21.00 per share. The primary offering is considered non-dilutive, as Guardian used its net proceeds to repurchase 1,440,447 outstanding shares of Class A Common Stock from certain stockholders in a “synthetic secondary” transaction.